Research / AEIS / Fundamental state Inspectable configuration
State dimensions Filing 0001558370-21-010102 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
86.78% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.50% · OPTIONAL · VALID
Operating cash generation 25th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.30% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
6.31% · CORE · VALID
Inventory pressure 95th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
82.13% · OPTIONAL · VALID
Gross margin 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
37.37% · CORE · VALID
Operating margin 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
11.37% · CORE · VALID
R&D intensity 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
11.10% · OPTIONAL · VALID
SBC intensity 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.95% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 57 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 90.38%
Current 86.78%
Delta -3.60% Capex Intensity Decreased
Previous 2.51%
Current 1.50%
Delta -1.01% Cash Generation Decreased
Previous 15.38%
Current 9.30%
Delta -6.08% Growth Decreased
Previous 11.46%
Current 6.31%
Delta -5.16% Inventory Pressure Increased
Previous 70.41%
Current 82.13%
Delta 11.72% Margin Decreased
Previous 39.11%
Current 37.37%
Delta -1.73% Profitability Decreased
Previous 12.57%
Current 11.37%
Delta -1.20% R And D Intensity Decreased
Previous 11.42%
Current 11.10%
Delta -0.32% Sbc Intensity Decreased
Previous 1.62%
Current 0.95%
Delta -0.67% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.